Our findings were in accord with previous studies on COVID-19 patients [13], and other respiratory infections like pneumonia [14], where the circulating copeptin level was raised and correlated with the severity and poor prognosis [15,19]. This evidence concerns the gene AVP and susceptibility to pneumonia measurement.